Find My AI Tool Logo
All tools

AgapeVerse

AgapeVerse is an AI poem generator that writes personal poems from details you provide about the person, occasion, and tone, which you can then edit, print, or share by link.

Writing ToolsCreative WritingPersonalPoetryGreeting & Gifts

About AgapeVerse

AgapeVerse

AgapeVerse lets users describe a person, an occasion, and a tone, then uses an AI language model to write a poem in seconds. Users can edit any line, keep poems private, print them on a typeset page, or share them by link, and can optionally publish to a poem library. Accounts are free and sign-in is available via Google, GitHub, or Discord. Each poem costs HeartPoints, which refill weekly. The page states that the AI writes poems only from the details provided, and that personal information is not sold and the people written about are never contacted. Premium plan offers a larger weekly HeartPoints allowance, hidden messages with visibility controls, and priority model quality, while the free plan includes 60 HeartPoints weekly with standard visibility and standard model quality.

Key features

  • AI-generated personal poems from a short form or chat-based Writing Desk
  • Line-by-line editing of generated poems
  • Private sharing by link
  • Print on a typeset page with clean typography and layout
  • Option to publish poems to a public poem library
  • Visibility controls and hidden messages (Premium)
  • Priority model quality for advanced poems (Premium)
  • Weekly HeartPoints refill; top-up HeartPoints purchases available

Best suited for

  • Birthdays
  • Anniversaries
  • Weddings
  • Apologies
  • Eulogies
  • Spontaneous 'just because' notes

Pricing

Free plan: ₹0 forever with 60 HeartPoints weekly minimum reset. Premium: ₹4,799 per year (save 17% with annual billing), or monthly billing option, with 1200 HeartPoints weekly allowance. HeartPoints top-ups: 100 HP for ₹49, 500 HP for ₹229, 1500 HP for ₹649.

poem generatorAI poetryHeartPointspersonal poemsgreeting poemsprintable poemspoem editor

Discussion

No comments yet. Start the conversation.